Recent advances in the development of melatonin MT1and MT2receptor agonists

Design, synthesis and pharmacological evaluation of novel naphthalenic derivatives as selective MT1 melatoninergic ligands

(2010) Christophe Mésangeau et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Synthesis of substituted N-[3-(3-methoxyphenyl)propyl] amides as highly potent MT2-selective melatonin ligands

(2010) Yueqing Hu et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Investigational melatonin receptor agonists

(2010) Rüdiger Hardeland   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Melatonin agonists and insomnia

(2010) Sally A Ferguson et al.   Expert Review of Neurotherapeutics

Effects of melatonin in experimental stroke models in acute, sub-acute, and chronic stages

(2010) Hsiao-Wen Lin et al.   Neuropsychiatric Disease and Treatment

Melatonin: Signaling mechanisms of a pleiotropic agent

(2009) Rüdiger Hardeland   BIOFACTORS

Melatonin and Melatonergic Drugs on Sleep: Possible Mechanisms of Action

(2009) Venkataramanujan Srinivasan et al.   INTERNATIONAL JOURNAL OF NEUROSCIENCE

Melatonin: A hormone that modulates pain

(2009) Mónica Ambriz-Tututi et al.   LIFE SCIENCES

Antiepileptic activity of melatonin in guinea pigs with pentylenetetrazol-induced seizures

(2009) İlker Solmaz et al.   NEUROLOGICAL RESEARCH

Sleep-promoting action of IIK7, a selective MT2 melatonin receptor agonist in the rat

(2009) Simon P. Fisher et al.   NEUROSCIENCE LETTERS

Circadian misalignment in mood disturbances

(2009) Alfred J. Lewy   Current Psychiatry Reports

Melatonin Receptor Agonists: SAR and Applications to the Treatment of Sleep-Wake Disorders

(2008) Silvia Rivara et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials

(2008) Shantha MW Rajaratnam et al.   LANCET